Showing results (11-20 of 1,544) with videos related to
Sort By:
Pageof 155
Journal of Pediatric Hematology/Oncology|June 11, 1999
Fludarabine-based protocol for human umbilical cord blood transplantation in children with Fanconi anemiaM Aker, G Varadi, S Slavin, et al.Bone Marrow Transplantation|February 18, 1998
A fludarabine-based protocol for bone marrow transplantation in Fanconi's anemiaJ Kapelushnik, R Or, S Slavin, et al.Medical Oncology (Northwood, London, England)|September 1, 1995
Role of interleukin-2 in human hematological malignanciesA Toren, A Ackerstein, S Slavin, et al.Journal of Hematotherapy|January 1, 1994
Treatment of chronic myelogenous leukemia with recombinant human interleukin-2 and interferon-alpha 2aA Nagler, A Ackerstein, V Barak, et al.Bone Marrow Transplantation|November 1, 1996
Bone marrow transplantation using unrelated and family related donors: the impact of HLA-C disparityA Nagler, C Brautbar, S Slavin, et al.Leukemia Research|January 1, 1996
The novel immunomodulator, Linomide, stimulates interleukin-2-induced human natural killer (NK) cell and PHA-stimulated T cell proliferation from normal donorsR Condiotti, S Slavin, V Barak, et al.Clinical and Experimental Immunology|June 1, 1995
Ketotifen therapy in chronic graft-versus-host disease (cGVHD): effect on mast cells and fibroblastsA Nagler, V Segal, S Slavin, et al.Cytokines, Cellular & Molecular Therapy|July 29, 1998
Cytokine gene transduction into non-immunogeneic murine tumor cellsS Morecki, A Lubina-Salomon, S Slavin, et al.Archives of Oral Biology|June 28, 2000
Partial protection of rat parotid glands from irradiation-induced hyposalivation by manganese superoxide dismutaseR M Nagler, A Z Reznick, S Slavin, et al.Cancer Genetics and Cytogenetics|April 1, 1994
Detection of minimal residual disease after sex-mismatch bone marrow transplantation in chronic myelogenous leukemia by fluorescence in situ hybridizationA Nagler, S Slavin, S Yarkoni, et al.Pageof 155